Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 19/20 | 0.46 |
| ▸ | PPARA | Q07869 | 16/20 | 0.46 |
| ▸ | PPARD | Q03181 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8662204 | 0.87 | POLB (0.39) | PPARGPPARACYP3A4CYP2C9KCNH2 | |
| SCHEMBL8500896 | 0.82 | KDM4E (0.46) | PPARGPPARAPPARDCYP3A4CYP2C9 | |
| SCHEMBL8445501 | 0.81 | PPARG (0.48) | PPARGPPARAPPARDCYP3A4CYP2C9 | |
| SCHEMBL8440666 | 0.79 | PPARG (0.47) | PPARGPPARAPPARDKDM4E | |
| SCHEMBL8444677 | 0.77 | PPARG (0.47) | PPARGPPARAPPARDCYP3A4CYP2C9 | |
| SCHEMBL8445498 | 0.76 | PPARG (0.47) | PPARGPPARAPPARDKDM4E | |
| SCHEMBL8472017 | 0.75 | POLB (0.45) | — | |
| SCHEMBL8471742 | 0.74 | MAPT (0.41) | KCNH2 | |
| SCHEMBL8659796 | 0.73 | MAPT (0.43) | PPARGCYP2C9KDM4E | |
| SCHEMBL6032173 | 0.72 | MAPT (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5939445-A | ISOXAZOLIDINEDIONES COMPOUNDS AS HYPOGLYCEMIC AGENTS AND TREATMENT OF ARTERIOSCLEROSIS | JAPAN TOBACCO, INC. (JP) | 1999-08-17 | — | — | US | disclosed |
| US-5728720-A | HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; TREATMENT OF DIABETES | JAPAN TOBACCO INC. (JP) | 1998-03-17 | — | — | US | disclosed |